πŸ† Finalist β€” NIH Data Sharing Index (β€œS-Index”) Challenge

Lei Guo

Guangzhou University of Chinese Medicine

ORCID: 0000-0003-2055-7618

Also affiliated with West Virginia University, Central South University, East China University of Science and Technology, University of Electronic Science and Technology of China, Army Medical University, Xinjiang Medical University, Indian Association for the Cultivation of Science, Shenzhen University, Dalian Medical University, Jilin University, California Institute for Regenerative Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, University of Washington, Peking University, Anhui University of Traditional Chinese Medicine, Bloodworks Northwest, West China Medical Center of Sichuan University, Hunan Provincial Center for Disease Control and Prevention, Daping Hospital, Second Affiliated Hospital of Chongqing Medical University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Anhui Science and Technology University, Hunan Cancer Hospital, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Zhejiang Modern Chinese Medicine and Natural Medicine Research Institute (China), The Affiliated Yongchuan Hospital of Chongqing Medical University, Peking University First Hospital, Chongqing Emergency Medical Center, China Academy of Chinese Medical Sciences, Xiangya Hospital Central South University, Chengdu University of Traditional Chinese Medicine, Xi'an Jiaotong University, Chongqing Medical University

Immunology and MicrobiologyMedicineAgricultural and Biological SciencesSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β€” papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6Β· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: β€œEffect on response to neoadjuvant chemotherapy in high-grade serous ovarian cancer by inhibiting the GAS6/AXL pathway and inducing homologous recombination deficiency.”.

0 citations

Elena Lomonosova, Michael Toboni, Hollie Noia, Danny Wilke, Alyssa Oplt +9 more